Skip to Content Skip to Content

Cancer Research

A FLASH of radiation may pave the way toward new cancer care for people and pets alike
Meg Ruller with her dog Maple in front of Penn Vet

(Homepage image) Meg Ruller, a 2018 graduate of the School of Veterinary Medicine, calls the FLASH trials “a fantastic opportunity” for Maple to receive a cutting-edge treatment—and to contribute to a scientific understanding of how FLASH radiation might help others in the future.

A FLASH of radiation may pave the way toward new cancer care for people and pets alike

Led by the Perelman School of Medicine’s Keith Cengel and the School of Veterinary Medicine’s Brian Flesner, a new study is evaluating the safety and efficacy of treating oral cancer in dogs with a palliative radiation in just two clinic visits.

Katherine Unger Baillie

NIH-funded canine immunotherapy data center charts a path toward transformative therapies
happy looking golden retriever in a clinic's kennel area

Researchers have learned much from treating dogs like Fantine, a golden retriever owned by Penn Vet supporter Richard Lichter, with immunotherapies for cancer, in part because tumors in dogs can closely resemble those in humans. With new support from the National Institutes of Health, a Penn-led team is ensuring such lessons can effectively translate into new therapeutic approaches. (Image: John Donges/Penn Vet)

NIH-funded canine immunotherapy data center charts a path toward transformative therapies

With support recently granted for five more years, Nicola Mason of the School of Veterinary Medicine and Qi Long of the Perelman School of Medicine hope their work leads to new insights in cancer care for people as well as pets.

Katherine Unger Baillie

Eight Penn scientists receive NIH grants through High-Risk, High-Reward Research program
Eight Penn scientists have received NIH grants through High-Risk, High-Reward Research program. They are pictured left to rigt top to bottom: Perelman School of Medicine’s Bushra Raj, Luca Busino, Donita Brady, Eric Witze, Terence Gade, Amelia Escolano, Chengcheng Jin, and George Burslem.

Eight Penn scientists have received NIH grants through High-Risk, High-Reward Research program. They are pictured left to right, top to bottom: Perelman School of Medicine’s Bushra Raj, Luca Busino, Donita Brady, Eric Witze, Terence Gade, Amelia Escolano, Chengcheng Jin, and George Burslem.

Eight Penn scientists receive NIH grants through High-Risk, High-Reward Research program

A group of five scientists received the Transformative Research Award for a project focusing on cancer research, while three investigators received the New Innovator Award for independent projects developed by early-career investigators.

Brandon Lausch

Understanding the needs of cancer care partners
Students Akin Adio and Abi Ocholi

Understanding the needs of cancer care partners

Through the Penn Undergraduate Research Mentoring Program, undergrads Abi Ocholi and Akin Adio deepened their understanding of qualitative research and of the experiences of caregivers.

Katherine Unger Baillie

$55M gift creates new ‘Cancer Interception’ Institute at Penn’s Basser Center for BRCA to stop hereditary cancers at the earliest stages
J. Larry Jameson, Susan Domcheck, Liz Magill, Mindy Gray, and Jon Gray in front of a sign that reads Basser Center for BRCA.

(Left to right) J. Larry Jameson, executive vice president of the University of Pennsylvania for the Health System; Susan Domchek, executive director of the Basser Center, Penn President Liz Magill, and Penn alumni Mindy and Jon Gray celebrate the gift to establish a new Basser Cancer Interception Institute.

$55M gift creates new ‘Cancer Interception’ Institute at Penn’s Basser Center for BRCA to stop hereditary cancers at the earliest stages

Funding for the Institute from Mindy and Jon Gray will propel early detection and prevention of breast, ovarian, pancreatic, and prostate cancers.

Holly Auer